Institute MECHNIKOV, created as part of the Russian and Nicaraguan project in Managua, began production of commercial batches of influenza vaccine. April 10. Managua. Institute MECHNIKOV has launched the production of a commercial vaccine batches in Managua (Nicaragua). The launch of the production lines was attended by the advisor for investments of the Government of
As part of the activities organized by the BIONICA project, which is coordinated by the vaccine plant MECHNIKOV and the National Autonomous University of Nicaragua (UNAN-Managua), from October 26 to November 2, the BIONICA camp was held at the UNAN-León. In that camp, Pharmaceutical Chemistry students of both universities shared their knowledge and experiences in
Director of SPbSRIVS Mr. Victor Trukhin y CEO of Mechnikov S.A. Mr. Stanislv Uiba took part in celebrations dedicated to the day of Nicaraguan Revolution. As part of the celebrations were held working meetings with the Nicaraguan colleagues of MECHNIKOV project. To remind, the Revolution Day is celebrated in Nicaragua at the national level on
The first shipment to Latin America of the Russian vaccine against yellow fever was the result of joint efforts by the St. Petersburg Research Institute of Vaccines and Serums (SPbSRIVS) of the Russian Federal Biomedical Agency and the Chumakov Federal Research Center for Research and Development of Immunobiological Preparations at the Russian Academy of Sciences.
  This Wednesday, February 3, the St. Petersburg Research Institute of Vaccines and Serums received the official Nicaraguan delegation led by the President of the Nicaraguan Social Insurance Institution (NSII), Dr. Roberto Lopez. Nicaraguan experts discussed with their Russian counterparts further steps to bring Russian-made vaccines, in particular influenza vaccines, and their synthesis technologies to